Clinical Research Organizations: Things to Consider Before Hiring Them
Posted Jan 07 2013 9:07am
It is a growing trend among pharmaceutical companies to outsource their clinical trials to specialized agencies called clinical or contract research organizations (CROs) in order to accelerate the drug development process. Go through this article that highlights some of the key factors a pharma (or sponsor) should consider before hiring contract research organizations.
Strategic Reasons to Outsource
It is essential that a sponsor pays maximum attention to strategic reasons to ascertain that they are optimizing the association and making the most of their relationship with a CRO. Effective planning of the trials is imperative with the four major conditions being the trial quality, flexibility, reporting technique and speed. A pharmacy that focuses on these conditions boosts its probability of success. Pharmaceutical companies should also comprehend that trial planning is vital to sustaining a uniform degree of control which they would have attained if they were carrying out the tests within their own facilities.
One of the primary reasons that drug companies opt for outsourcing their trials is the decrease in fixed costs. Furthermore, it will probably be more cost-effective to hire a contract research organization that already has sophisticated technology in place, instead of attempting and executing this technology within their business. The same is applicable to professional know-how. Utilizing qualified and experienced manpower in a different facility can be more affordable than imparting the requisite training to their own staff.
Outsourcing internationally to contract research organizations brings into play issues like quality of data, cultural significances, communication procedures, statutory regulations and legalities.
Labor expenditure is the key factor behind outsourcing since it generally constitutes about 80 percent of the entire trial cost. Though the global labor cost is considerably cheaper in up-and-coming markets, the turnover of workforce at global facilities might be substantially higher. This is because of the speedy growth in the number of research labs. As soon as novel facilities come into being, competent members of the workforce are recruited from other existing clinical research organizations. The sponsor must analyze the training records of any potential partner and select an organization that boasts well qualified manpower working at the facility for a prolonged period of time.